Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Norris Medicines Ltd, at its meeting on September 1, 2025, approved the appointment of M/s. Dhiren Y Parikh & Co., Chartered Accountants as Internal Auditors for FY 2025-26. It also appointed M/s. HSPN Associates LLP, Company Secretaries, as Secretarial Auditors for a five-year term covering FY 2025-26 to FY 2029-30. Both firms are based in Mumbai, with HSPN having over 30 years of corporate law and compliance experience. The company stated the appointments will strengthen internal audit, transparency, and regulatory compliance. No resignations or cessations were disclosed in this filing.
These are routine governance appointments with no impact on share price or shareholder value. They may modestly improve audit quality and compliance standards but do not signal any strategic or financial change.